I was hoping that some kind of valuation could be thrown on the wall for the TMR sensors. The prospective $3bn addressable market for the biochip sensor is just the beginning - that's only one disease, and things do need replacing over time. Other devices for other diseases. Very promising that we're looking to bridge the gap between no income and getting a product on the market, plus forging relationships with a partner company of which we can potentially use rights/IP for payment to help us get to the point where we can make a profit. Happy for the 12CQ to take a back seat to avoid a cap raise, get some profit flowing from the biochip, and potentially TMR sensors, and then use these to leapfrog our 12CQ development.
I'm not buying any more right now because I've definitely over-invested, but, I don't think there's ever been a better time to buy AXE shares. It really is only a matter of time before this SP blows up.
AXE Price at posting:
26.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)